• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导致抗凝控制不佳的因素。

Pathways to poor anticoagulation control.

机构信息

Center for Healthcare Organization and Implementation Research, Bedford VA Medical Center, Bedford, MA, USA; Department of Medicine, Section of General Internal Medicine, Boston University School of Medicine, Boston, MA, USA.

出版信息

J Thromb Haemost. 2014 May;12(5):628-34. doi: 10.1111/jth.12530.

DOI:10.1111/jth.12530
PMID:24548552
Abstract

BACKGROUND

While a considerable amount is known about which patient-level factors predict poor anticoagulation control with warfarin, measured by percent time in therapeutic range (TTR), less is known about predictors of time above or below target.

OBJECTIVE

To identify predictors of different patterns of international normalized ratio (INR) values that account for poor control, including 'erratic' patterns, where more time is spent both above and below INR target, and unidirectional patterns, where time out of range is predominantly in one direction (low or high).

METHODS

We studied 103 897 patients receiving warfarin with a target INR of 2-3 from 100 Veterans Health Administration sites between October 2006 and September 2008. Our outcomes were percent time above and below the target range. Predictors included patients' demographics, comorbidities, and other clinical data.

RESULTS

Predictors of erratic patterns included alcohol abuse (5.2% more time below and 3.7% more time above, P < 0.001 for all results), taking > 16 medications (4.6% more time below and 1.8% more time above compared to taking seven or fewer medications), and four or more hospitalizations during the study (6.6% more time below and 2% more time above compared to no hospitalization). In contrast, predictors like cancer, non-alcohol drug abuse, dementia, and bipolar disorder were associated with more time below the target range (3.4%, 5.2%, 2.6%, and 3.2%, respectively) and less (or similar) time above range.

CONCLUSION

Different patient-level factors predicted unidirectional below-target and 'erratic' patterns of INR control. Distinct interventions are necessary to address these two separate pathways to poor anticoagulation.

摘要

背景

尽管已经了解了许多与华法林抗凝治疗控制不佳(以治疗范围内时间百分比[TTR]衡量)相关的患者水平因素,但对于高于或低于目标时间的预测因素了解较少。

目的

确定不同国际标准化比值(INR)值模式的预测因素,这些模式可解释控制不佳的原因,包括“不规则”模式,即更多时间处于 INR 目标值上下;以及单向模式,即超出目标范围的时间主要在一个方向(高或低)。

方法

我们研究了 2006 年 10 月至 2008 年 9 月期间,来自 100 个退伍军人健康管理局站点的 103897 名接受华法林治疗且 INR 目标值为 2-3 的患者。我们的结局是高于和低于目标范围的时间百分比。预测因素包括患者的人口统计学特征、合并症和其他临床数据。

结果

不规则模式的预测因素包括酒精滥用(低于目标的时间多 5.2%,高于目标的时间多 3.7%,所有结果均 P<0.001)、服用>16 种药物(低于目标的时间多 4.6%,高于目标的时间多 1.8%,而服用 7 种或更少药物)和研究期间住院 4 次或以上(低于目标的时间多 6.6%,高于目标的时间多 2%,而无住院)。相比之下,癌症、非酒精药物滥用、痴呆和双相情感障碍等预测因素与低于目标范围的时间更长(分别为 3.4%、5.2%、2.6%和 3.2%)和高于目标范围的时间更短(或相似)相关。

结论

不同的患者水平因素预测了 INR 控制的单向低于目标和“不规则”模式。需要采取不同的干预措施来解决这两种不同的抗凝不良途径。

相似文献

1
Pathways to poor anticoagulation control.导致抗凝控制不佳的因素。
J Thromb Haemost. 2014 May;12(5):628-34. doi: 10.1111/jth.12530.
2
Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA).与口服抗凝控制相关的患者特征:退伍军人事务部改善抗凝研究(VARIA)的结果。
J Thromb Haemost. 2010 Oct;8(10):2182-91. doi: 10.1111/j.1538-7836.2010.03996.x.
3
Quality of warfarin management in primary care: Determining the stability of international normalized ratios using a nationally representative prospective cohort.初级保健中华法林管理的质量:使用全国代表性的前瞻性队列确定国际标准化比值的稳定性。
Can Fam Physician. 2019 Jun;65(6):416-425.
4
Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation.非瓣膜性心房颤动新使用华法林患者的国际标准化比值超出范围与医疗保健费用。
J Med Econ. 2015 May;18(5):333-40. doi: 10.3111/13696998.2014.1001851. Epub 2015 Feb 6.
5
Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range.改善抗凝治疗的质量测量:在治疗范围内的时间百分比中加入国际标准化比值变异性。
Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):664-9. doi: 10.1161/CIRCOUTCOMES.114.000804. Epub 2014 Sep 2.
6
Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.波兰初级保健患者中维生素 K 拮抗剂的口服抗凝治疗质量控制:一项多中心研究。
Kardiol Pol. 2018;76(4):764-769. doi: 10.5603/KP.2018.0011. Epub 2018 Jan 9.
7
Depression as a Driving Force for Low Time in Therapeutic Range and Dementia in Patients With and Without Atrial Fibrillation.抑郁是导致伴有和不伴有心房颤动的患者治疗范围内时间不足和痴呆的驱动力。
Am J Cardiol. 2021 Aug 15;153:58-64. doi: 10.1016/j.amjcard.2021.05.021. Epub 2021 Jun 25.
8
International normalized ratio stability in warfarin-experienced patients with nonvalvular atrial fibrillation.华法林治疗的非瓣膜性心房颤动患者的国际标准化比值稳定性
Am J Cardiovasc Drugs. 2015 Jun;15(3):205-11. doi: 10.1007/s40256-015-0120-9.
9
Anticoagulation Control, Outcomes, and Associated Factors in Patients with Atrial Fibrillation Receiving Warfarin at Tertiary Care Hospital in Ethiopia.抗凝控制、结局及在埃塞俄比亚三级医院接受华法林治疗的房颤患者的相关因素。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211049786. doi: 10.1177/10760296211049786.
10
A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa.乌干达和南非五个华法林抗凝服务的横断面评估。
PLoS One. 2020 Jan 29;15(1):e0227458. doi: 10.1371/journal.pone.0227458. eCollection 2020.

引用本文的文献

1
Potential Candidates for Biomarkers in Bipolar Disorder: A Proteomic Approach through Systems Biology.双相情感障碍生物标志物的潜在候选物:通过系统生物学的蛋白质组学方法
Clin Psychopharmacol Neurosci. 2022 May 31;20(2):211-227. doi: 10.9758/cpn.2022.20.2.211.
2
The impact of mental health conditions on oral anticoagulation therapy and outcomes in patients with atrial fibrillation: A systematic review and meta-analysis.心理健康状况对心房颤动患者口服抗凝治疗及预后的影响:一项系统评价和荟萃分析。
Am J Prev Cardiol. 2021 Jun 27;7:100221. doi: 10.1016/j.ajpc.2021.100221. eCollection 2021 Sep.
3
Social determinants of atrial fibrillation.
心房颤动的社会决定因素
Nat Rev Cardiol. 2021 Nov;18(11):763-773. doi: 10.1038/s41569-021-00561-0. Epub 2021 Jun 2.
4
Quality of anticoagulation with warfarin in rural Chhattisgarh, India.印度恰蒂斯加尔邦农村地区华法林抗凝治疗的质量。
Indian J Med Res. 2020 Sep;152(3):303-307. doi: 10.4103/ijmr.IJMR_1201_18.
5
Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study.魁北克华法林队列研究的原理、设计与初步结果。
Clin Cardiol. 2018 May;41(5):576-585. doi: 10.1002/clc.22948. Epub 2018 May 15.
6
Time in therapeutic range: Warfarin anticoagulation for atrial fibrillation in a community-based practice.治疗范围内时间:基于社区实践的心房颤动华法林抗凝治疗。
Can Fam Physician. 2017 Oct;63(10):e425-e431.
7
Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation.新诊断心房颤动患者华法林治疗窗时间的临床预测模型。
J Am Heart Assoc. 2017 Oct 12;6(10):e006669. doi: 10.1161/JAHA.117.006669.
8
Educational Level, Anticoagulation Quality, and Clinical Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study.老年急性静脉血栓栓塞症患者的教育水平、抗凝质量及临床结局:一项前瞻性队列研究
PLoS One. 2016 Sep 8;11(9):e0162108. doi: 10.1371/journal.pone.0162108. eCollection 2016.
9
Impact of age on long-term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient management.年龄对长期抗凝治疗的影响以及性别和监测环境如何对其产生影响:对决策制定和患者管理的启示
Br J Clin Pharmacol. 2016 Oct;82(4):1076-83. doi: 10.1111/bcp.13046. Epub 2016 Jul 24.
10
Pillbox Use and INR Stability in a Prospective Cohort of New Warfarin Users.新华法林使用者前瞻性队列中的用药盒使用与 INR 稳定性。
J Manag Care Spec Pharm. 2016 Jun;22(6):676-84. doi: 10.18553/jmcp.2016.22.6.676.